Literature DB >> 1312092

Mevalonate kinase is localized in rat liver peroxisomes.

K D Stamellos1, J E Shackelford, R D Tanaka, S K Krisans.   

Abstract

Recent data suggest that rat liver peroxisomes play a critical role in cholesterol synthesis. Specifically, peroxisomes contain a number of enzymes required for cholesterol synthesis as well as sterol carrier protein-2. Furthermore, peroxisomes are involved in the in vitro synthesis of cholesterol from mevalonate and contain significant levels of apolipoprotein E, a major constituent of several classes of plasma lipoproteins. In this study we have investigated the subcellular localization of mevalonate kinase (EC 2.7.1.36; ATP:mevalonate-5-phosphotransferase). Mevalonate kinase is believed to be a cytosolic enzyme and catalyzes the phosphorylation of mevalonate to form mevalonate 5-phosphate. Mevalonate kinase has been purified from rat liver cytosol and a cDNA clone coding for rat mevalonate kinase has also been isolated and characterized. In this study, utilizing monoclonal antibodies made against the purified rat mevalonate kinase, we demonstrate the presence of mevalonate kinase in rat liver peroxisomes and in the cytosol. Each of these compartments contained a different form of the protein. The pI and the Mr of the peroxisomal protein is 6.2 and 42,000, respectively. The pI and Mr of the cytosolic protein is 6.9 and 40,000, respectively. The peroxisomal protein was also significantly induced by a number of different hypolipidemic drugs. In addition, we present evidence for the unexpected finding that the purified mevalonate kinase (isolated from the cytosol and assumed to be a cytosolic protein) is actually a peroxisomal protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312092

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Peroxisomal localization of Arabidopsis isopentenyl diphosphate isomerases suggests that part of the plant isoprenoid mevalonic acid pathway is compartmentalized to peroxisomes.

Authors:  Maya Sapir-Mir; Anahit Mett; Eduard Belausov; Shira Tal-Meshulam; Ahuva Frydman; David Gidoni; Yoram Eyal
Journal:  Plant Physiol       Date:  2008-11       Impact factor: 8.340

2.  Cholesterol biosynthesis in Zellweger syndrome: normal activity of mevalonate kinase, mevalonate-5'-pyrophosphate decarboxylase and IPP-isomerase in patients' fibroblasts but deficient mevalonate kinase activity in liver.

Authors:  R J Wanders; G J Romeijn
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Cholesterol biosynthesis, peroxisomes and peroxisomal disorders: mevalonate kinase is not only deficient in Zellweger syndrome but also in rhizomelic chondrodysplasia punctata.

Authors:  R J Wanders; G J Romeijn
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 4.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

5.  Segregation of the N301T mutation in the family of the index patient with mevalonate kinase deficiency.

Authors:  B Goebel-Schreiner; R Schreiner; G F Hoffmann; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway in mammalian peroxisomes.

Authors:  Werner J Kovacs; Khanichi N Tape; Janis E Shackelford; Xueying Duan; Takhar Kasumov; Joanne K Kelleher; Henri Brunengraber; Skaidrite K Krisans
Journal:  Histochem Cell Biol       Date:  2006-12-19       Impact factor: 4.304

7.  Unique behavior of Trypanosoma cruzi mevalonate kinase: A conserved glycosomal enzyme involved in host cell invasion and signaling.

Authors:  Éden Ramalho Ferreira; Eduardo Horjales; Alexis Bonfim-Melo; Cristian Cortez; Claudio Vieira da Silva; Michel De Groote; Tiago José Paschoal Sobreira; Mário Costa Cruz; Fabio Mitsuo Lima; Esteban Mauricio Cordero; Nobuko Yoshida; José Franco da Silveira; Renato Arruda Mortara; Diana Bahia
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.